
New study identifies gene variants influencing weight loss and side effects from obesity drugs like semaglutide, potentially aiding personalized treatment approaches.

New genetic insights explain why some people lose more weight and others feel sick from popular diet drugs, paving the way for tailored treatments.
Amgen’s MariTide, a monthly injectable GLP-1 drug, could challenge Eli Lilly’s dominance, offering a convenient alternative for weight loss and diabetes.